BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Alliances
IXICO Announces New Contract In Huntington’s Disease 4/24/2015
Bayer MaterialScience AG Names BioAmber Inc. As Its Supplier For New Product Line - Bio-Succinic Acid Forms Backbone Of Innovative New Bio-Based Polyurethanes For Textiles 4/24/2015
Celgene (CELG) Slaps Down $450 Million Upfront for AstraZeneca PLC (AZN)'s Prized Immunotherapy Blood Cancer Drug 4/24/2015
Innate Pharma (IPH.PA ) Strikes Cancer Pact Worth $1.275 Billion With Pharma Giant AstraZeneca PLC (AZN) 4/24/2015
The Dow Chemical Company (DOW) Commemorates Five Year Partnership With The Philadelphia Science Festival 4/24/2015
SD Mines, Arizona State University Pave Way For Cooperative Research 4/24/2015
Synchrogenix, Certara Corporation’s Regulatory Writing Consultancy, And CISCRP Partner To Help Biopharm Companies Meet Clinical Data Transparency Requirements 4/23/2015
MedImmune (AZN) And Juno Therapeutics (JUNO) Announce Immuno-Oncology Clinical Trial Collaboration 4/23/2015
RegenRx And Dimension Therapeutics Add Development Of Treatments For Two Metabolic Diseases To Exclusive License Agreement 4/23/2015
TxCell And Trizell Amend Collaboration Agreement To Accelerate Ovasave Development 4/23/2015
MRC Technology Collaborates With NYU School Of Medicine To Develop Biologics For Inflammatory Bone Disease 4/23/2015
KineMed, Inc. And Camino Partnership Announce Collaboration To Create Portfolio Of Clinical Drug Candidates 4/23/2015
Transgenomic, Inc. (TBIO) To Incorporate Horizon Discovery Ltd.’s Genomic Reference Standards Into Multiplexed Ice Cold-PCR Kits 4/23/2015
Georgia Bio And The Innovation Crescent Regional Partnership (ICRP) Sign Agreement To The Promote Life Science Industry In Georgia 4/23/2015
Agilent Technologies Inc. (A) To Collaborate With National University of Singapore (NUS) On Bioanalytical Studies 4/23/2015
CryoPort, Inc. To Support The Equine Animal Husbandry Market Through Agreement With Yancey Farms 4/23/2015
Generex Biotechnology Corporation (GNBT) Announces New $11 Million Collaboration On Buccal Cannabis 4/23/2015
GTX Corp And The University of Tennessee Research Foundation Enter Into Exclusive License Agreement To Develop UTRF’s SARD Drug Technology 4/23/2015
Atossa Genetics, Inc. (ATOS) Secures In-Network Contract With Meridian Health Plan Of Michigan 4/23/2015
Easton Pharmaceuticals (OP: EAPH) Announces Finalized Joint Partnership Agreement With BMV Medica For Exclusive Rights To Distribute World Patented Women's Health Diagnostic Test In Mexico From Israel-Based Common Sense Ltd. 4/23/2015
DanDrit Biotech And Riyadh Pharma Sign Partnership Agreement 4/23/2015
Recipharm AB Is Commencing Negotiations With LIDDS On Large-Scale Manufacture Of Liproca Depot 4/23/2015
Vigilant Biosciences Announces Two Poster Presentations At The 2015 AACR Annual Meeting 4/23/2015
Noxilizer And Getinge-La Calhène Announce Exclusive Global Supply Agreement For Noxilizer To Provide NOX FLEX Rapid Biodecontamination Systems For Getinge Isolators – Providing A New Solution For The Bio-Pharmaceutical Industry 4/23/2015
The Charcot-Marie-Tooth Association Enters Collaboration With Lead Discovery Center’s Subsidiary Affectis To Advance Therapies For Charcot-Marie-Tooth 1A Disorder 4/22/2015
Admedus Appoints Genpharm As Distributor For Cardiocel In Middle East And North Africa 4/22/2015
XstalBio: Parasite Vaccines On the Horizon With Xstalbio Microparticle Formulations 4/22/2015
IDBS And ChemAxon Ltd. Partnership Harnesses Leading Biology And Chemistry Expertise 4/22/2015
BioTime (BTX) Licenses Beckman Research Institute Of City of Hope To Manufacture Clinical Grade Stem Cells 4/22/2015
PaxVax, Inc. Announces Global Expansion Of Commercial Network For Its Typhoid Vaccine Vivotif 4/22/2015
Vical Incorporated (VICL) To Manufacture HIV Vaccines For Clinical Evaluation By Public-Private Partnership Initiative 4/22/2015
Astellas Pharma US And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 4/22/2015
Ligand Pharmaceuticals Inc. (LGND) Earns Milestone From SAGE Therapeutics For SAGE-547 4/22/2015
Axxess Pharma, Inc. Signs Major Manufacturing, Marketing And Distribution Agreement With Chinese Manufacturer 4/22/2015
Kunming Biomed To Offer Its Non-Human Primates In U.S. Through BTS Research 4/22/2015
CluePoints’ Central Statistical Monitoring Solution With Oracle Health Sciences Cloud Can Enable Proactive Risk-Based Monitoring And Improve Data Quality 4/22/2015
Perkins+Will To Provide Architecture And Design Services For NIH’s $150 Million Building 10 E Wing Renovation Project In Bethesda, MD 4/22/2015
Pain Therapeutics (PTIE) Resumes Responsibility For REMOXY 4/21/2015
YourEncore And ACRES Partner To Drive Innovation In Clinical Research 4/21/2015
Optibrium And Certara Corporation Collaborate On Integration Of StarDrop And D360 4/21/2015
CorTechs Labs, Inc. Announces Partnership To Provide Comprehensive Solutions For Quantifying Brain Volume Loss In Multiple Sclerosis 4/21/2015
GenVec Inc. (GNVC) Announces Collaboration With The Laboratory Of Malaria Immunology & Vaccinology 4/21/2015
NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 4/21/2015
Edico Genome Collaborates With Intel Corporation (INTC) To Overcome Big Data Bottleneck In Next-Generation Sequencing 4/21/2015
MaxCyte, Inc. And Johns Hopkins University Announce Strategic Immuno-Oncology Collaboration To Advance CAR T-Cell Therapies 4/21/2015
Easton Pharmaceuticals (OP: EAPH) Announces A Signed Agreement With Colorado Product Services, LLC And Cultiv8, LLC Towards The Purchase Of A Recreational Marijuana Dispensary, Cultivation Facility And Lab In Carbondale, Colorado 4/21/2015
Cleveland Clinic Lou Ruvo Center For Brain Health Announces Agreement To Support The Professional Fighters' Brain Health Study And Provide Services In Connection With The Premier Boxing Champions Series 4/21/2015
WIRB-Copernicus Group Supports Adoption Of Accelerated Clinical Trial Agreement By WCG Global Research Network 4/21/2015
ClinEdge, LLC Announces Collaboration With Sister Company BlueTheory Clinical Trials, LLC 4/21/2015
Bina Technologies And AstraZeneca PLC (AZN) Announce Collaborative Agreement For Global Deployment Of Bina’s Genomic Management Solution 4/21/2015
Tiny Curadev Wrangles a $555 Million Pact With Drug Giant Roche (RHHBY) 4/20/2015
Applied Genetic Technologies Corporation And 4D Molecular Therapeutics Sign Collaboration Agreement For Gene Therapy Vector Discovery And Product Development 4/20/2015
NeoStem, Inc. Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma (KITE) 4/20/2015
TetraLogic Pharmaceuticals (TLOG) And Merck & Co. (MRK) To Collaborate On The Evaluation Of Birinapant In Combination With KEYTRUDA (Pembrolizumab) In Solid Tumors 4/20/2015
Cellular Biomedicine Group (CBMG) Engages Huntsworth Health To Build Global KOL Advocacy For Knee Osteoarthritis Stem Cell Rejoin(TM) Clinical Trials 4/20/2015
Horizon Discovery Group plc And Thermo Fisher Scientific (TMO) Sign Supply And Commercialization Agreement 4/20/2015
Qualyst, Inc. Transporter Solutions Announces New License Deal With Bioreliance On New Transporter Knock-out Products And Services 4/20/2015
PointCross Life Sciences And InterpretOmics Partner For Clinical And Genomic Biomarker Management For Drug Development 4/20/2015
TD2 And Navigating Cancer Partner To Bring Patient-Reported Outcomes To Clinical Trials Through A Cutting-Edge Mobile Application 4/20/2015
SillaJen Presents Data Demonstrating Pexa-Vec Synergy With Angiogenesis Inhibitors: A Collaboration With University of California, San Francisco (UCSF) 4/20/2015
Takeda (TKPYY) Bets $269 Million+ with CiRA for 100-Scientist 10-Year Stem Cell R&D Pact 4/17/2015
Novogen Limited (NVGN) And Feinstein Institute Join Forces To Find Effective Treatments For Brain Cancer 4/17/2015
NeuroVive Chooses New Stroke Partner After To-BBB's Restructuring and Collaboration Concludes 4/17/2015
Panther Biotechnology Announces New Drug Candidate To Selectively Kill Leukemia Stem Cells 4/17/2015
Igantia Therapeutics Partners With Fogarty Institute Of Innovation 4/17/2015
Theranostics Health Announces Agreements With Avera Health For Research Collaborations And Coverage Of Theralink Assay 4/17/2015
4SC Pockets €95 Million Upfront From Resminostat Deal With Menarini Asia-Pacific Group (Formerly Invida Group) 4/17/2015
IBM (IBM)'s New Boston Health Unit Will House 2,000 Employees 4/16/2015
Pfizer (PFE)'s Screening Process Sorts the Legit Partnerships From the Casual Flings 4/16/2015
Genmab A/S (GEN.CO) Achieves USD 10 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 4/16/2015
Regeneron (REGN) CEO Heads to Cuba With N.Y. Trade Delegation 4/16/2015
Eli Lilly (LLY) Snags North American Rights to Erbitux From Bristol-Myers Squibb (BMY) 4/16/2015
Immunocore Limited And MedImmune (AZN) Announce New Collaboration To Conduct Immuno-Oncology Combination Trails In Melanoma 4/16/2015
Lancet And ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 4/16/2015
Pivotal Therapeutics Inc. Executes Memorandum Of Understanding For Exclusive Distribution Of Benefishial Line Of Products In Korea 4/16/2015
Autifony Therapeutics Announces £3.3 Million Collaboration To Progress First-In-Class Drug For Schizophrenia Into Clinical Trials 4/16/2015
Asklepios BioPharmaceutical, Inc. Executes License With Benitec Limited (BLT.AX) 4/16/2015
NovaBay Pharmaceuticals, Inc. (NBY) Signs Distribution Agreement With AmerisourceBergen Corporation (ABC) For Avenova 4/16/2015
RainDance Technologies Extends Global Commercial Reach With Distributor Appointments In Europe And Middle East 4/16/2015
SillaJen Announces Agreement With The FDA For A Special Protocol Assessment For Upcoming Phase 3 Pexa-Vec Trial In Advanced Liver Cancer 4/16/2015
Quintiles (Q) And Hospital Italiano Of Buenos Aires Announce Agreement To Accelerate Clinical Development 4/16/2015
BioCision, LLC And Brooks Joint Development Partnership To Unveil New Cryogenic Sample Handling And Transport Product 4/16/2015
GeoVax Labs Inc. (GOVX.OB) Enters Into Research Collaboration Agreement With The NIH For Ebola/Marburg Vaccines 4/16/2015
Cystic Fibrosis Foundation Therapeutics, Inc. Announces $14 Million Research Expansion With Genzyme (GENZ) 4/16/2015
H. Lundbeck A/S (LUN.CO) And Ovid Technologies Announce Exclusive Worldwide Licensing Agreement For Gaboxadol 4/16/2015
The ALS Association, Harvard Stem Cell Institute, And Massachusetts General Hospital Neurological Clinical Research Institute Collaborate With GlaxoSmithKline (GSK) On New ALS Clinical Trial 4/16/2015
Coherus And Baxter International (BAX) Announce Amendment To Etanercept Biosimilar Collaboration Agreement 4/15/2015
Heart Metabolics Limited And FDA Reach Agreement On Special Protocol Assessment For Single Phase 3 Trial Of Perhexiline In Hypertrophic Cardiomyopathy 4/15/2015
SELLAS Life Sciences Group And Trojantec Ltd. Sign Exclusive License Agreement For Global Rights On Development And Commercialization Of Innovative TR-1 Anti-Cancer Antennapedia Technology 4/15/2015
Ophthalmology-Focused CROs, Iris Pharma And Oculos Clinical Research Announce Strategic Alliance To Offer International Specialized Services To The Ophthalmic Market 4/15/2015
IBBL Joins Forces With Europe’s Biggest Players In Cancer Research 4/15/2015
China's NHWA Pharma To Start Trial Of In-Licensed Epilepsy Drug 4/15/2015
Guided Therapeutics, Inc. Books Investment, Signs MOU With Potential China Distributor 4/15/2015
Florida Atlantic University Signs Collaboration Agreement With Internationally Renowned Nansen Neuroscience Network In Norway 4/15/2015
Heart Metabolics And FDA Reach Agreement On Special Protocol Assessment For Single Phase 3 Trial Of Perhexiline In Hypertrophic Cardiomyopathy 4/15/2015
Optibrium And ChemAxon Announce Technology Collaboration 4/15/2015
Lexicon Pharmaceuticals, Inc. (LXRX) And Bristol-Myers Squibb (BMY) Select Development Candidate For Neuropathic Pain In Neuroscience Drug Discovery And Development Alliance 4/15/2015
Argos Therapeutics, Inc. (ARGS) Licenses Arcelis Technology Platform To Lummy HK For Development Of Personalized Immunotherapies To Treat Cancer In China 4/15/2015
Celgene (CELG), Mesoblast (MSB.AX) $45M Deal "Speaks Volumes" About Big Pharma's Cell Therapy Plans, Says Pluristem Therapeutics (PSTI) 4/14/2015
BioReference Laboratories, Inc. (BRLI) Partners With Organizations Accelerating Medical Innovation 4/14/2015
Pressure BioSciences, Inc. (BBII) To Collaborate With Southern University At New Orleans On Improving And Extending The Use Of PBI's PCT Platform For The Detection Of DNA In Forensic Samples 4/14/2015
Multiple Myeloma Research Foundation (MMRF), University Of Torino, And Adaptive Biotechnologies Work To Speed Novel Minimal Residual Disease Monitoring Technologies To Patients 4/14/2015
IBM (IBM) & Apple (AAPL) Expand Partnership To Help Transform Medical Research 4/14/2015
THERAVECTYS Secures Exclusive Access To A Synthetic Humanized Nanobody Library From Institut Curie And Strengthens Its Proprietary Immunotherapeutic Platform 4/14/2015
Abbott (ABT) And Sekisui Collaborate To Offer Coagulation Testing For Laboratories Worldwide 4/14/2015
Lead Discovery Center And AstraZeneca PLC (AZN) Broaden Drug Discovery Alliance 4/14/2015
UMBC Partnership With Northrop Grumman (NOC) Expands To Include Health Data Analytics 4/14/2015
Recipharm AB Makes Strategic Investment In Synthonics And Partners In Development Of Novel Compounds 4/14/2015
Aptuit LLC And Axxam SpA Announce Strategic Alliance For Integrated Drug Discovery Services 4/14/2015
REGiMMUNE Announces Collaboration With Juvenile Diabetes Research Foundation And Pfizer (PFE) For Type 1 Diabetes Prevention And Treatment Promoting Regulatory T-Cells 4/14/2015
Elevance Expands Customer Service And Support Capabilities In U.S. And Europe For Elevance Aria WTP 40 Customers 4/14/2015
Mesoblast (MSB.AX) Hits Highest Point in a Decade, as Celgene (CELG) Bets $45 Million 4/13/2015
PharmAthene, Inc. (PIP) Receives $5.8 Million Payment From BARDA 4/13/2015
Hydra Biosciences, Inc. And Boehringer Ingelheim Enter Research Collaboration Focused On Renal Diseases And Disorders 4/13/2015
PatientsLikeMe And AstraZeneca PLC (AZN) Announce Global Research Collaboration 4/13/2015
Humabs BioMed Reports Clinical Milestone In MedImmune (AZN) Partnership 4/13/2015
Affymetrix (Santa Clara, California) (AFFX) And Evergene Ltd., A Subsidiary Of MTI Ltd., Collaborate In Genetic Research And Personal Genomics Services In Japan 4/13/2015
Medivir AB (MVRBF) And Cancer Research Technology Collaborate To Develop New Class Of Cancer Drugs 4/13/2015
TVM Capital Life Science Announces Initiation Of Investment Operations Of China Biopharma Capital I Venture Capital Fund, With First Close Of $50 Million 4/13/2015
TRACON Pharmaceuticals, Inc. (TCON) Expands License Agreement And Signs Research Agreement With Case Western Reserve University 4/9/2015
BioXcel And Takeda (TKPYY) Partner To Repurpose Assets For Orphan Diseases 4/9/2015
Amyris, Inc. And Squalan Natural Health Partner To Accelerate Development And Sales Of Neossance Personal Care Products 4/9/2015
Arvinas Strikes $434 Million Collaboration with Merck & Co. (MRK) to Continue Thriving in Connecticut 4/8/2015
Targacept (TRGT), Catalyst Biosciences Merger in Jeopardy After Pfizer (PFE) Pulls Plug on Deal 4/8/2015
Ipsen (IPN.PA) And Hannover Medical School Start Joint Research In Recombinant Botulinum Neurotoxins For Targeted Secretion Inhibitors 4/8/2015
Compass Point Research To Collaborate With NDA Partners To Develop Migraine Combination Drug 4/8/2015
Orgenesis Signs Cell Therapy Product Development Memorandum Of Understanding With CureCell Of Korea 4/8/2015
AmorChem l.p. Invests In Projects At The Personalized Cancer Immunotherapy Program 4/8/2015
Inovio Pharmaceuticals (INO) Selected By Defense Advanced Research Projects Agency To Lead A $45 Million Program To Expedite Development Of Novel Products To Prevent And Treat Disease Caused By Ebola 4/8/2015
REGENXBIO Licenses Key Technologies From University of Pennsylvania And University of Minnesota For The Development Of Treatments For MPS I And MPS II 4/8/2015
Merus Reaches Pivotal Milestone In Bispecific Antibody Collaboration With Ono Pharmaceutical Company, Ltd. 4/8/2015
Cortendo AB Joins National Organization for Rare Disorders (NORD) Corporate Council 4/8/2015
F2G License Cresset’s Forge To Complement Successful Consulting Projects 4/8/2015
Padlock Therapeutics Initiates Collaborations With Three Leading Research Partners On The Biology Of PAD Enzymes 4/8/2015
PPD, Inc. (PPDI) And SNBL Complete Joint Venture To Provide Japanese Clinical Development Services And Additional Collaborations 4/8/2015
uniQure (QURE) Soars After Bristol-Myers Squibb (BMY) Bets $1 Billion on Gene Therapy Platform 4/7/2015
Caris Life Sciences And COTA Enter Collaboration To Measure Clinical And Economic Impact Of Evidenced-Based Drug Selection For Precision Medicine In Oncology 4/7/2015
VBI Vaccines Announces Research Collaboration With Sanofi Pasteur (SASY.PA) To Enhance Vaccine Stability 4/7/2015
Taxus Cardium (CRXM) Announces Agreement With Dr. Reddy's Laboratories Ltd. (RDY) To Co-Develop, Market & Sell Generx Angiogenic Microvascular Gene Therapy In Certain International Markets 4/7/2015
Breakout Labs And Becton, Dickinson and Company (BDX) Partner To Provide Capital And Expertise To Biomedical Startups 4/7/2015
Amphivena Therapeutics Achieves Development Milestones Under Agreement With Janssen Biotech Inc. (JNJ) 4/7/2015
Vernalis PLC (VNLPY.PK) Enters Into Research Collaboration With Taisho Pharmaceutical 4/7/2015
Global Strategic Partners Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) Finalize Agreement To Co-Promote XALKORI (Crizotinib) 4/7/2015
Our Vision Is To Cure Alzheimer’s Disease: Health Connexions And Recombinant Technologies Announce A Ground-Breaking Partnership To Accelerate Success In Alzheimer’s Disease 4/7/2015
DSG, Inc. Partners With Soligenix (SNGX) To Battle Cutaneous T-Cell Lymphoma 4/7/2015
Phylogica Ltd. Enters Transaction With UK Biotech To Identify And Develop Small Molecule Cancer Drugs 4/7/2015
Orgenesis To Collaborate With The Global Stem Cell & Regenerative Medicine Acceleration Center Of Korea 4/7/2015
Advaxis, Inc. And RTOG Foundation To Collaborate On Pivotal Phase 2/3 Clinical Trial Of ADXS-HPV In Anal Cancer 4/6/2015
ProtoKinetix Inc. (PKTX.OB) Announces Consulting Agreements 4/6/2015
Cytori Therapeutics, Inc. (CYTX) Receives China Opening Product Purchase Order From Licensee 4/6/2015
MorphoSys AG CEO Believes Drug Isn't Dead Even After Celgene (CELG) Abandons $818 Million Pact 4/6/2015
Radlink Announces Exclusive Sales Agency Agreement With Johnson & Johnson (JNJ) Subsidiary DePuy Synthes Companies 4/3/2015
MD Anderson Cancer Center, Astellas Pharma Inc. (ALPMY) Sign Option Agreement For Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia 4/3/2015
BIND Therapeutics (BIND) Announces Extension Of Global Collaboration With Pfizer (PFE) To Develop And Commercialize Multiple Accurins 4/3/2015
Sanofi (SAN.PA) Inks a $120 Million Drug Design Pact to Help Guide Lackluster Drug Discovery Programs 4/2/2015
Quintiles (Q), Quest Diagnostics (DGX) to Combine and Form Global Clinical Trial Lab Joint Venture 4/2/2015
Intrexon Corporation Signs Cooperative Research And Development Agreement (CRADA) With The National Cancer Institute For RheoSwitch Controlled IL-12 Cancer Therapies Using T Cell Receptors (TCR) Derived From Peripheral Blood 4/2/2015
OncoMed Pharmaceuticals, Inc. (OMED) And Eli Lilly (LLY) Enter Clinical Supply Agreement To Evaluate The Combination Of Demcizumab And Alimta (Pemetrexed For Injection) In Lung Cancer 4/2/2015
Nektar Therapeutics (NKTR) Announces Receipt Of $100 Million Milestone Payment From AstraZeneca PLC (AZN) 4/2/2015
Cold Spring Harbor Laboratory And North Shore-LIJ Announce Strategic Affiliation To Accelerate Benefits Of Cancer Research To Patients 4/2/2015
Sanford-Burnham Medical Licenses Small Molecule To Daiichi Sankyo For Further Development 4/2/2015
Baxter International (BAX) And Laboratoire Aguettant Announce Global Collaboration For Parenteral Nutrition Trace Elements 4/2/2015
Peptidream Announces License Of PeptiDream's Peptide Discovery Platform System (PDPS) Technology To Peptidream 4/2/2015
Ipsen (IPN.PA) Expands Ties To Harvard University With Signing Of A New Research Alliance Agreement 4/2/2015
BioMed Realty Forms New Relationship With Stanford Health Care With New 138,000 Square Foot Lease At Pacific Research Center 4/2/2015
MultiCorp International, Inc. Engages Compass Point Research To Collaborate With NDA Partners To Develop Patented Migraine Combination Drug 4/2/2015
Massachusetts Biotechnology Council, Inc. Announces New Collaborations With Science, Banker & Tradesman & DrugPatentWatch 4/2/2015
Tiny Aduro Biotech Snags $750M Cancer Deal With Drug Giant Novartis AG (NVS) 4/1/2015
Covance Inc. (CVD) And Sihuan Pharmaceutical Initiate Partnership In Preclinical And Clinical Portfolio Development 4/1/2015
VLP Therapeutics Enters Collaboration With Institute Of Tropical Medicine, Nagasaki University 4/1/2015
Portage Biotech's Biohaven Announces Agreement With inVentiv Health (VTIV) 4/1/2015
Teijin Limited Signs Sales Agreement For New Anti-inflammatory Analgesic Patch Formulation 4/1/2015
Brickell Biotech Signs Exclusive License And Development Agreement For BBI-4000 With Kaken Pharmaceuticals 4/1/2015
Stellar Biotechnologies, Inc. And Neovacs SA Expand KLH Supply Relationship 4/1/2015
Panther Biotechnology Announces Exclusive License Agreement With Northwestern University 4/1/2015
Myriad Genetics, Inc. (MYGN) And AstraZeneca PLC (AZN) Expand Research Collaboration On Lynparza 4/1/2015
Neurocrine Biosciences, Inc. (NBIX) And Mitsubishi Tanabe Pharma Corporation Announce Agreement To Develop And Commercialize VMAT2 Inhibitor NBI-98854 For Movement Disorders In Japan And Other Select Asian Markets 4/1/2015
Merck Serono, Intrexon Corporation Ink $941M Pact, As Race for CAR-T Edge Continues 3/31/2015
Teva (TEVA) Wins $170 Million Contract To Make Vaccine In Forest 3/31/2015
Syndax Pharmaceuticals Inc. And Merck & Co. (MRK) To Collaborate On Immuno-Oncology Study Evaluating Entinostat In Combination With KEYTRUDA (Pembrolizumab) In Lung Cancer And Melanoma 3/31/2015
Alzheimer's Drug Discovery Foundation Funds Signum Biosciences to Move Novel Therapeutics Towards Clinic 3/31/2015
AEterna Zentaris (AEZS) Signs Transfer Agreement Of Its Discovery Library With The Medical University of South Carolina 3/31/2015
Biocryst Pharmaceuticals (BCRX) Awarded BCX4430 Advanced Development Contract 3/31/2015
Bayer HealthCare (BAY) Expands Collaboration With Broad Institute Of MIT And Harvard University To Develop Therapies For Cardiovascular Disease 3/31/2015
Merck And China Animal Husbandry Sign Partnership MOU 3/31/2015
Lead Discovery Center And Helmholtz Centre for Infection Research Enter Partnership For The Discovery Of New Drugs Against Multi-Resistant Bacteria 3/31/2015
Cold Spring Harbor Laboratory Engages Hairpin Technologies Inc. To License Its Short Hairpin RNA (shRNA) Technology 3/31/2015
Quintiles (Q) And Quest Diagnostics (DGX) To Form Joint Venture To Provide Global Clinical Trials Laboratory Services 3/31/2015
X-Chem And Navitor Pharmaceuticals Enter Into License Agreement On Novel Small Molecules Targeting mTORC1 Activation 3/31/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/30/2015
The Biopharmaceutical Business Of Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Intrexon Corporation Announce Agreement For The Development And Commercialization Of CAR-T Therapy 3/30/2015
Aegerion (AEGR) Reaches Agreement With Sarissa Capital 3/30/2015
Baxter International (BAX) Expands Access To Healthcare Through Collaborations And Charitable Giving 3/30/2015
SCIEX And Mass Consortium Corporation Announce Exclusive Reseller Agreement Of XCMSplus Metabolomics Software 3/30/2015
Cell Therapy Catapult Signs Multiple Collaboration Agreements 3/30/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/27/2015
RXi Pharmaceuticals (RXII) And Mirimmune LLC Enter Into An Exclusive Licensing Agreement For RXi's Self-Delivering RNAi (sd-rxRNA) Technology To Develop Cell-Based Immunotherapies To Treat Cancer 3/27/2015
Google (GOOG)'s Mystery Biotech Calico Cuts Local Longevity R&D Pact 3/26/2015
Helsinn Group Signs Exclusive Agreement With Mundipharma For Distribution And Licence Of Anamorelin In China, Hong Kong And Macao 3/26/2015
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015